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Abstract 
Background: Repeated implantation failure (RIF) is defined as pregnancy failure 
after two to six times with at least ten high grade embryo transfer to uterus. A 
variety of causes have been anticipated for RIF, including anatomical, autoimmune, 
genetics, endocrine and thrombotic anomalies. Factors responsible for RIF have 
important implication regarding treatment however in many couples a perfect cause 
cannot be found. 
Cases: In these case series, we reported nine couples with RIF that after 
investigation no definitive etiology was found for RIF and empirical therapy by 
heparin, aspirin and or immunotherapy was not effective. In these cases we 
recommended transfer of embryos to surrogate uterus. Nine patients were studied 
and six of them developed a normal pregnancy (pregnancy rate=66.66%). 
Conclusion: This study showed that surrogacy is a good option for treatment of 
RIF. 
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Introduction 
 
ssisted reproductive technology has 
been progressed during recent years 
(1, 2). Despite of the introduction of 
enhanced protocols for ovarian stimulation 
and improved culturing techniques for embryo 
development, it has been estimated that live 
birth-rate per cycle is ranged from 29.9-43.7% 
(3). Repeated implantation failure (RIF) was 
defined as pregnancy failure after two to six 
times with at least ten high grade embryo 
transfer to uterus (1).  
Successful implantation requires a 
receptive endometrium, a good embryo and 
synchronization between endometrium and 
embryos. The endometrium undergoes a 
series of proliferative and secretory 
alterations, and endometrial receptivity exist in 
a short time of cycles, recognized as the 
“implantation window” (4). Endometrial 
development needs the perfect association of 
a really large number of different aspects. 
Although our information of endometrial 
receptivity is incomplete, it may still allow for 
important development in the organization of 
female infertility (5).  
A variety of causes have been anticipated 
for RIF, including anatomical, autoimmune, 
genetics, endocrine and thrombotic anomalies 
(6, 7). Recent evidence suggested that these 
different abnormalities increase levels of 
circulating natural killer cells and interfere with 
implantation (8). Factors responsible for RIF 
have important implication regarding 
treatment however in many couples a 
definitive cause cannot be found (9). Although 
many molecules concerned in implantation 
have been recognized in humans, microarray 
analysis of the endometrium has only 
presented an insight into the role of a few 
molecules (5).  
The molecular mechanisms which control 
endometrial-blastocyst interaction remain 
poorly clear. In this case series, we reported a 
series of couple with RIF that after 
investigation no definitive etiology was found 
for RIF and empirical therapy by heparin, 
aspirin and or immunotherapy was not 
effective. In these cases In order to exclude 
intrauterine factors that might impede embryo 
implantation, we recommended transfer of 
embryos to surrogate uterus. 
 
Case Series 
 
We reported a case series of patients with 
history of RIF at Yazd Research and Clinical 
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Center for Infertility of Shahid Sadoughi 
University of Medical Sciences and Yazd 
Madar Hospital, from January 2009 to 
December 2011. A signed informed consent 
was obtained from all of the patients who 
participated in the study. Basic demographic 
characteristic of patients is presented in table 
I. All of the couples had history of transfer of 
high quality embryos in previous cycles. 
Evaluation of uterine cavity by vaginal 
sonography, hysteroscopy and/or 
sonohysterography showed normal uterine 
cavity. Lupus anticoagulant, anti-cardiolipin 
antibodies, protein S and protein C were 
measured in all of the cases and the values 
were reported in normal ranges. Karyotypes of 
all couples were normal.  
Females were between 27-43 years old. 
According to the request of couples, we 
suggested transferring the obtained embryos 
to a surrogate’s uterus. Less than three 
embryos were transferred. All of the surrogate 
mothers were less than 35 years old with the 
history of at least one normal pregnancy that 
was resulted to live healthy baby. 
Cryopreserved embryos were used in all of 
the patients. Endometrial preparation was 
similar in all surrogate mothers. 
Estradiol vale rate (Estradiol vale rate, 
Aburaihan Co., Tehran, Iran) was started 
orally at the dose of 6 mg per day from the 
second day of menstrual cycle. Endometrial 
thickness was assessing by vaginal 
ultrasonography and when endometrial 
thickness reach more than 8 mm in diameter 
progesterone in oil (progesterone Aburaihan 
Co., Tehran, Iran) 100 mg IM daily was 
injected. Estradiol and progesterone 
administration was continued until the 
documentation of fetal heart activity by 
ultrasound. Thawing of the embryos was done 
two days after starting of progesterone 
injection. Embryos were transferred by using a 
Labotect (Labotect, Gottingen, Germany). 
Nine patients were studied and six of 
surrogate mothers developed a normal 
pregnancy (pregnancy rate=66.66%). No 
abortion was seen among these cases. 
Case 1: a 34 year-old woman with history 
of ten years infertility and history of 
implantation failure for five times.  
Case 2: 32 years old with the history of 
infertility for ten years and five times 
implantation failure. Sonography showed 
pattern of adenomyosis of uterus.  
Case 3: 27 years old with the history of 
primary infertility for nine years and three 
times in vitro fertilization (IVF) that leads to 
early abortion.  
Case 4: 27 years old with the history of six 
years infertility and implantation failure for four 
times. Surrogate mother delivered healthy 
twin pregnancy. 
Case 5: 39 years old with the history of 
infertility for eight years and three times 
history of repeated implantation failure.  
Case 6: 36 years old with the history of 
fourteen years infertility and six times IVF 
failure. Sonography showed adenomyosis.  
In all of these cases surrogacy resulted in 
pregnancy. No pregnancy was achieved in 
three others cases.  
Case 7: 36 years old with the history of 
primary infertility for seven years, RIF for three 
times. Myomectomy was done five years ago 
and the patient had no myoma during IVF.   
Case 8: 43 years old with the history of 
infertility for ten years and implantation failure 
for three times.  
Case 9: 35 years old with the history of 
infertility for fifteen years and history of 
implantation failure for three times.  
 
 
 
Table I. Basic characteristic of patients 
Variable Minimum Maximum Mean ±SD 
Female age (years) 
 
27 43 34.22 ± 4.99 
Infertility duration (years) 
 
3 15 8.33 ± 3.42 
Basal  FSH (mIU/ml) 
 
4 10 6.88 ± 1.90 
BMI (Kg/m2) 
 
21 29 24.44  ± 2.60 
Etiology of infertility                   Number (%)   
Male factor  
 
3 (33.33)   
Tubal factor  
 
2 (22.22)   
Ovarian factor  
 
2 (22.22)   
Unexplained  
 
2 (22.22)   
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Discussion 
 
In this case series we showed that 
surrogacy provide a good chance for 
pregnancy in patients with the history of RIF. 
We reported 66.66% pregnancy rate in nine 
patients. Three surrogate mother failed IVF 
again after use of surrogate uterus but one of 
the cases was a 43 year-old woman. Age is 
an independent factor for success of IVF and 
so failure of IVF in this case may be due to 
advance age of mother. Kling et al in their 
study for evaluation of pregnancy outcome 
after recurrent implantation failure reported 
16.9% birth rate after fresh embryo transfer. In 
their study they showed that age is a 
prognostic factor for success in patient with 
RIF and pregnancy rate significantly 
decreased in women older than 39 (10).  
In case 3 the patient had a history of three 
time’s early abortion after embryo transfer. 
Recently it has been hypothesized that 
recurrent pregnancy loss and implantation 
failure have similar pathology and it was 
suggested that same factors that are 
important for fetal survival may by responsible 
for implantation failure (1, 11). According to 
this hypothesis we recommended surrogacy 
to the couple and fortunately achieved live 
birth. Two out of nine cases showed 
adenomyosis in sonography.  
Study demonstrated that adenomyosis is a 
potential cause in RIF and endometrial biopsy 
showed that adenomyosis was associated 
with increased aggregation of macrophages 
within superficial endometrial gland that can 
interfere with embryo implantation (12). Many 
maternal factors were suggested as etiology 
of RIF. However the role of these factors in 
the patients with RIF is a matter of debate and 
no agreement in the literature exist regarding 
effectiveness and necessity of evaluate of the 
factor in IVF outcomes. Besides sometimes 
no definitive etiology is found for RIF and no 
pregnancy achieve after treatments modality. 
Endometrial receptivity now seems to be 
the restricted access of the implantation. 
Basic and clinical research will assist to 
progress understanding of the events of 
endometrial preparation for implantation. 
Microarray technology has spread vision, and 
has resulted in a number of gene expression 
analysis studies helped at translating answer 
into clinical application (13). This information 
could considerably improve the management 
of female infertility. More information is 
needed about molecular study and therapeutic 
options to treat endometrial dysfunction and 
improve implantation. Therefore it seems that 
elimination of endometrial factor by using 
surrogate mother may shed light on the 
unsolved question of the cases at unexplained 
RIF. 
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